Related Experiment Video
Updated: Aug 11, 2026

Screening Ion Channels in Cancer Cells
Published on: June 16, 2023
Ether à go-go potassium channels and cancer
1Pharmacology Section, Centro de Investigación y de Estudios Avanzados del Instituto Politécnico Nacional, Avenida Instituto Politécnico Nacional 2508, México, DF 07360, México. fcamacho@cinvestav.mx
Abstract:
Ion channels play important roles in health and disease. In the last few years, an interesting relationship between potassium channels and cancer has evolved. Especially, members of the ether à go-go (EAG) potassium channels family have gained interest as research tools for detection and therapy of different cancers. This review will summarize most of the findings relating EAG channels and cancer, focusing on mRNA expression in tissues, oncogenic properties, modulation and pharmacology. Plausible scenarios on the cellular mechanisms of EAG oncogenicity will be discussed.
Insights
Ether à go-go (EAG) potassium channels are increasingly important in cancer research. This review explores their role in cancer detection and therapy, focusing on expression, oncogenic properties, and cellular mechanisms.
Area of Science:
- Molecular Biology
- Oncology
- Ion Channel Physiology
Background:
- Ion channels are crucial for cellular functions and implicated in various diseases.
- A growing body of evidence links potassium channels, particularly EAG family members, to cancer development and progression.
Purpose of the Study:
- To review current findings on the relationship between ether à go-go (EAG) potassium channels and cancer.
- To focus on EAG channel mRNA expression, oncogenic properties, and pharmacological modulation in the context of cancer.
Main Methods:
- Literature review of studies investigating EAG channels in cancer.
- Analysis of research on EAG channel mRNA expression in cancerous tissues.
- Examination of studies detailing the oncogenic properties and cellular mechanisms of EAG channels.
Main Results:
- Ether à go-go (EAG) potassium channels are frequently dysregulated in various cancers.
- EAG channels exhibit oncogenic properties, influencing cell proliferation, migration, and survival.
- Modulation and pharmacology of EAG channels present potential therapeutic strategies for cancer treatment.
Conclusions:
- Ether à go-go (EAG) potassium channels represent promising targets for cancer detection and therapy.
- Further research into the cellular mechanisms of EAG oncogenicity is warranted to develop effective treatments.
Related Concept Videos
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Non-gated Ion Channels
Compared to the gated ion channels, the non-gated channels, also known as leakage or passive channels, have no gating mechanism.
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Voltage-gated Ion Channels
Generally, all voltage-gated ion channels have a 'voltage-sensing domain' that spans the lipid bilayer. The charged residues in the sensor move in response to the membrane potential changes that open the channel allowing ions movement. There are several types of...
Antiepileptic Drugs: Potassium Channel Activators
Ezogabine has gained approval as an adjunctive treatment...
G-Protein Gated Ion Channels
Sensory organs,...

